ASHLEY TAYLOR: Open Payments
NPI 1821313651 · YUKON, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 31 payments from 17 companies in 2025. Trend: 2023 $529 · 2024 $465 · 2025 $570
Food & beverage: $570
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $143 |
| Lilly USA, LLC | 4 | $70 |
| PFIZER INC. | 3 | $60 |
| Organon LLC | 2 | $35 |
| Alexion Pharmaceuticals, Inc. | 1 | $33 |
| Novo Nordisk Inc | 2 | $30 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Dexcom, Inc. | 1 | $26 |
| Lundbeck LLC | 1 | $22 |
| Viatris Specialty LLC | 1 | $20 |
Products named: UBRELVY, MOUNJARO, NURTEC ODT, VRAYLAR, NEXPLANON, STRENSIQ, Ozempic, Dexcom G6 Transmitter.
Industry payments across OK — which companies pay providers there.
